The first half of 2026 brought a more permissive environment for technology M&A in the United States and a more mature, assertive phase of ...
The Center for AI Enabling Discovery in Disease Biology (AID2B) applies artificial intelligence and machine learning techniques to customize treatments using patient data, combating biases in medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results